Home Markets Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Jun 17, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/eli-lilly-nears-13-billion-deal-for-geneediting-biotech-verve-therapeutics-ft-reports-4098210

You May Also Like

Apple now makes 25% of iPhones in India amid China shift, Bloomberg reports

Iran says oil blockade will continue until attacks end, Trump threatens to hit harder

US solar installations down in 2025 after Trump policies jolt market, report says

HPE projects revenue above estimates, focuses on higher-margin networking orders

Nvidia planning to launch open source AI agent platform- Wired

German publishers reject Apple’s revised app tracking rules, urge antitrust fine